Cervico-Facial Vascular Malformations

  • Jeyaledchumy Mahadevan
  • Hortensia Alvarez
  • Pierre Lasjaunias


Craniofacial vascular lesions are best categorized into hemangiomas (i.e., showing proliferation and potential involution) and vascular malformations (i.e., not showing such behavior) [1]. While hemangiomas and PHACE syndrome will briefly be dealt with at the end of this chapter, vascular malformations are the main focus of this paper.


Neural Crest Arteriovenous Malformation Vascular Malformation Hereditary Hemorrhagic Telangiectasia Venous Malformation 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Mulliken JB, Glowacki J. Hemangiomas and vascular malformations of infants and children: a classification based on endothelial characteristics. Plast Reconstr Surg 1982; 69:412–422.PubMedGoogle Scholar
  2. 2.
    Burrows P, Mulliken JB, Fellows KE, Strand RD. Childhood hemangiomas and vascular malformations: angiographic differentiation. AJR Am J Roentgenol 1983; 14:483–488.Google Scholar
  3. 3.
    Jackson IT, Carreno R, Potparic Z, Hussain K. Hemangiomas, vascular malformations, and lymphovenous malformations: classification and methods of treatment. Plast Reconstr Surg 1993; 91:1216–1230.CrossRefPubMedGoogle Scholar
  4. 4.
    Fishman SJ, Mulliken J. Hemangiomas and vascular malformations of infancy and childhood. Pediatr Surg 1993; 40:117–120.Google Scholar
  5. 5.
    Mulliken JB, Young A. Vascular Birthmarks, Hemangiomas and Malformations. Philadelphia: Saunders, 1988.Google Scholar
  6. 6.
    Wisnicki JL. Hemangiomas and vascular malformations. Ann Plast Surg 1984; 12:41–59.CrossRefPubMedGoogle Scholar
  7. 7.
    McAllister KA, Grogg KM, Johnson DW, Gallione CJ, Baldwin MA, Jackson CE, Helmbold EA, Markel DS, McKinnon WC, Murrell J, et al. Endoglin, a TGF-b binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type. Nature Genet 1994; 8:345–351.CrossRefPubMedGoogle Scholar
  8. 8.
    Couly G, Coltey P, Eichmann A, Le Douarin NM. The angiogenic potentials of the cephalic mesoderm and the origin of brain and head blood vessels. Mech Dev 1995; 52:1–16.Google Scholar
  9. 9.
    Bhattacharya JJ, Luo CB, Suh DC, Alvarez H, Rodesch P, Lasjaunias P. Wyburn-Mason or Bonnet-Dechaume-Blanc as cerebrofacial arteriovenous metameric syndromes (CAMS). A new concept and a new classification. Interventional Neuroradiology 2001; 7:5–17.PubMedGoogle Scholar
  10. 10.
    Ramli N, Sachet M, Boa C, Lasjaunias P. Craniofacial venous metemeric syndrome (CVMS) 3: Sturge-Weber syndrome with bilateral lymphatic/venous malformations of the mandible. Neuroradiology 2003; 45:687–690.CrossRefPubMedGoogle Scholar
  11. 11.
    Meyer JS, Hoffer FA, Barnes PD, Mulliken JB. Biological classification of soft-tissue vascular anomalies: MR correlation. AJR Am J Roentgenol 1991; 157:559–564.PubMedGoogle Scholar
  12. 12.
    Konez O, Burrows P, Mulliken JB. Cervicofacial venous malformations MRI features and intervention strategies. Interventional Neuroradiology 2002; 8:227–234.PubMedGoogle Scholar
  13. 13.
    Lasjaunias P, Berenstein A. Endovascular treatment of craniofacial lesions. Surgical Neuroangiography, vol 2. Berlin: Springer, 1987.Google Scholar
  14. 14.
    Riles TS, Berenstein A, Fisher FS, Persky MS, Madrid M. Reconstruction of the ligated external carotid artery for embolization of cervicofacial arteriovenous malformations. J Vasc Surg 1993; 17:491–498.CrossRefPubMedGoogle Scholar
  15. 15.
    Burrows P, Lasjaunias P, ter Brugge K, Flodmark O. Urgent and emergent embolization of lesions of the head and neck in children: indications and results. Pediatrics 1987; 80:386–394.PubMedGoogle Scholar
  16. 16.
    Forbes G, Franklin I, Jackson IT, Marsh WR, Jack CR, Cross SA. Therapeutic embolization angiography for extra-axial lesions in the head. Mayo Clin Proc 1986; 61:427–441.PubMedGoogle Scholar
  17. 17.
    Komiyama M, Khosla V, Yamamoto Y, Tazaki H, Toyota M. Embolization in high-flow arteriovenous malformations of the face. Ann Plast Surg 1992; 78:575–585.Google Scholar
  18. 18.
    Terada T, Nakamura Y, Nakal K, Tsuura M, Nishiguchi T, Hayashi S, Kido T, Taki W, Iwata H, Komal N. Embolization of arteriovenous malformations with peripheral aneurysms using ethylene vinyl alcohol copolymer. J Neurosurg 1991; 75:655–660.CrossRefPubMedGoogle Scholar
  19. 19.
    Goldberg RA, George H, Garcia BA, Duckwiler GR. Combined embolization and surgical treatment of arteriovenous malformation of the orbit. Am J Ophthalmol 1993; 116:17–25.PubMedGoogle Scholar
  20. 20.
    Chiras J, Hassine D, Goudot P, Meder JF. Treatment of arteriovenous malformations of the mandible by arterial and venous embolization. AJNR Am J Neuroradiol 1990; 11:1191–1194.PubMedGoogle Scholar
  21. 21.
    Flandroy P, Pruvo JP. Treatment of mandibular arteriovenous malformations by direct transosseous puncture: report of two cases. Cardiovasc Intervent Radiol 1994;17:222–225.CrossRefPubMedGoogle Scholar
  22. 22.
    Resnick SA, Russell E, Hanson DH, Pecaro BC. Embolization of a life-threatening mandibular vascular malformation by direct percutaneous transmandibular puncture. Head Neck 1992; 107:372–379.CrossRefGoogle Scholar
  23. 23.
    Shultz RE, Richardson D, Kempf KK, Pevsner PH, George ED. Treatment of a central arteriovenous malformation of the mandible with cyanoacrylate: a 4-year follow-up. Oral Surg Oral Med Oral Pathol 1988; 65:267–277.CrossRefPubMedGoogle Scholar
  24. 24.
    Van den Akker HP, Kuiper L, Peeters FL. Embolization of an arteriovenous malformation of the mandible. J Oral Maxillofac Surg 1997; 45:255–260.Google Scholar
  25. 25.
    Persky MS, Yoo HJ, Berenstein A. Management of vascular malformations of the mandible and maxilla. Laryngoscope 2003; 113:1885–1892.CrossRefPubMedGoogle Scholar
  26. 26.
    Enjolras O, Mulliken JB, Boon LM, Wassef M, Kozakewich HP, Burrows PE. Noninvoluting congenital hemangioma: a rare cutaneous vascular anomaly. Plast Reconstr Surg 2001; 107:1647–1654.CrossRefPubMedGoogle Scholar
  27. 27.
    Berenguer B, Mulliken JB, Enjolras O, Boon LM, Wassef M, Josset P, Burrows PE, Perez-Atayde AR, Kozakewich HP. Rapidly involuting congenital hemangioma: clinical and histopathologic features. Pediatr Dev Pathol 2003; 6:495–510.CrossRefPubMedGoogle Scholar
  28. 28.
    Enjolras O, Mulliken JB. Clinical and laboratory investigations: the current management of vascular birthmarks. Pediatr Dermatol 1993; 10:311–333.CrossRefPubMedGoogle Scholar
  29. 29.
    Jacobs AH, Walton RG. The incidence of birthmarks in the neonate. Pediatrics 1976; 58:218–222.PubMedGoogle Scholar
  30. 30.
    Burns AJ, Kaplan L, Mulliken JB. Is there an association between hemangiomas and syndromes with dysmorphic features? Pediatrics 1991; 88:1257–1267.PubMedGoogle Scholar
  31. 31.
    Bioxeda P, de Misa RF, Arrazola JM, Perez B, Harto A, Ledo A. Facial angioma and the Sturge-Weber syndrome: a study of 121 cases. Med Clin (Barc) 1993; 101:1–4.Google Scholar
  32. 32.
    Enjolras O, Riche M, Merland JJ. Sturge-Weber syndrome: facial port-wine stains and Sturge-Weber syndrome. Pediatrics 1985; 76:48–51.PubMedGoogle Scholar
  33. 33.
    Erba G, Cavazzuti V. Sturge-Weber syndrome: natural history and indications for surgery. J Epilepsy 1990; 3(Suppl):287–291.Google Scholar
  34. 34.
    Burrows PE, Fellows KE. Techniques for management of pediatric vascular anomalies. In: Cope C (ed) Current Techniques in Interventional Radiology. Philadelphia: Current Medicine, 1995.Google Scholar
  35. 35.
    Dubois JM, Sebag G, de Prost, Teillac D, Chretien B, Brunelle F. Soft-tissue venous malformations in children; percutaneous sclerotherapy with ethibloc. Radiology 1991; 180:195–198.PubMedGoogle Scholar
  36. 36.
    Berenstein A, Kricheff II. Theurapeutic vascular occlusion. J Dermatol Surg Oncol 1978; 4:874–880.PubMedGoogle Scholar
  37. 37.
    Anavi Y, Har-El G, Mintz S. The treatment of facial hemangioma by percutaneous injections of sodium tetradecyl sulfate. J Laryngol Otol 1988; 102:87–90.CrossRefPubMedGoogle Scholar
  38. 38.
    Goebel WM, Lucatorto FM. Sodium tetradecyl sulfate treatment of benign vascular anomalies. J Oral Med 1976; 31:76–80.PubMedGoogle Scholar
  39. 39.
    Govrin-Yehudain J, Moscona A, Calderon N, Hirshowitz B. Treatment of hemangiomas by sclerosing agents: an experimental and clinical study. Ann Plast Surg 1987; 18:465–469.CrossRefPubMedGoogle Scholar
  40. 40.
    Pappas DC Jr, Persky MS, Berenstein A. Evaluation and treatment of head and neck venous vascular malformations. Ear Nose Throat J 1998;77:914–916, 918–922.PubMedGoogle Scholar
  41. 41.
    Yakes WF, Haas DK, Parker SH, Gibson MD, Hopper KD, Mulligan JS, Pevsner PH, Johns JC, Carter TE. Symptomatic vascular malformations: ethanol embolotherapy. Radiology 1989; 170:1059–1066.PubMedGoogle Scholar
  42. 42.
    Yakes W, Baker R. Cardio-pulmonary collapse: sequelae of ethanol embolotherapy [Abstr]. Radiology 1993; 189:145.Google Scholar
  43. 43.
    Gorenstein A, Katz S, Rein A, Schiller M. Giant cystic hygroma associated with venous aneurysm. J Pediatr Surg 1992; 27:1504–1506.CrossRefPubMedGoogle Scholar
  44. 44.
    Joseph AE, Donaldson J, Reynolds M. Neck and thorax venous aneurysm: association with cystic hygroma. Radiology 1989; 170:109–112.PubMedGoogle Scholar
  45. 45.
    Ravitch MM, Bush BJ. Cystic hygroma. In: Welch KJ (ed) Pediatric Surgery, 4th edn. Chicago: Yearbook Medical, 1986:533–539.Google Scholar
  46. 46.
    Lasjaunias P, Burrows P, Planet C. Developmental venous anomalies (DVA): the so-called venous angioma. Neurosurg Rev 1986; 9:233–242.CrossRefPubMedGoogle Scholar
  47. 47.
    Takahashi K, Mulliken JB, Kozakewich HP, Rogers RA, Folkman I, Ezekowitz RAB. Cellular markers that distinguish the phases of hemangioma during infancy and childhood. J Clin Invest 1994; 93:2357–2364.CrossRefPubMedGoogle Scholar
  48. 48.
    Ezekowitz RA, Phil D, Mulliken JB, Folkman J. Interferonalpha-2 therapy for life-threatening hemangiomas of infancy. N Engl J Med 1992; 326:1456–1463.PubMedCrossRefGoogle Scholar
  49. 49.
    Bar-Sever Z, Horev G, Lubin E, Kornreich L, Naor N, Ziv N. A rare coexistence of a multicentric hepatic hemangioendothelioma with a large brain hemangioma in a preterm infant. Pediatr Radiol 1994; 24:141–142.CrossRefPubMedGoogle Scholar
  50. 50.
    Enjolras O, Riche MC, Merland JJ, Escande JP. Management of alarming hemangiomas in infancy: a review of 25 cases. Pediatrics 1990; 85:491–498.PubMedGoogle Scholar
  51. 51.
    Edgerton MT. The treatment of hemangiomas: with special reference to the role of steroid therapy. Ann Surg 1976; 183:517–532.CrossRefPubMedGoogle Scholar
  52. 52.
    Orchard PJ, Smith CM, Woods WG, Day DL, Dehner LP, Shapiro R. Treatment of haemangioendotheliomas with alpha interferon. Lancet 1989; 2:1565–1567.Google Scholar
  53. 53.
    Warner M, Suen JY, Dinehart S, Mallory SB. Laser photocoagulation of superficial proliferating hemangiomas. J Dermatol Surg Oncol 1994; 20:43–46.Google Scholar
  54. 54.
    Konior RJ, Holinger LD, Russell EJ. Superselective embolization of laryngeal hemangioma. Laryngoscope 1988; 98:830–834.CrossRefPubMedGoogle Scholar
  55. 55.
    Larsen EC, Zinkham WH, Eggleston JC, Zitello BJ. Kasabach-Merritt syndrome: therapeutic considerations. Pediatrics 1987; 79:971–980.PubMedGoogle Scholar
  56. 56.
    Grimal I, Duveau E, Enjolras O, Verret Jl, Ginies JL. Effectiveness and dangers of interferon-alpha in the treatment of severe hemangiomas in infants. Arch Pediatr 2000; 7:163–167.CrossRefPubMedGoogle Scholar
  57. 57.
    Enjolras O, Breviere GM, Roger G, Tovi M, Pellegrino B, Varotti E, Soupre V, Picard A, Leverger G. Vincristine treatment for function-and life-threatening infantile hemangioma. Arch Pediatr 2004; 11:99–107.CrossRefPubMedGoogle Scholar
  58. 58.
    Frieden IJ, Reese V, Cohen D. PHACE syndrome. The association of posterior fossa brain malformations, hemangiomas, arterial anomalies, coarctation of aorta and cardiac defects and eye abnormalities. Arch Dermatol 1996; 132:307–311.CrossRefPubMedGoogle Scholar
  59. 59.
    Rossi A, Bava GL, Biancheri R, Tortori-Donati P. Posterior fossa and arterial abnormalities in patients with facial capillary hemangioma: presumed incomplete phenotypic expression of PHACES syndrome. Neuroradiology 2001; 43:934–940.CrossRefPubMedGoogle Scholar
  60. 60.
    Luo CB, Bhattacharya JJ, Ferreira MS, Alvarez H, Rodesch G, Lasjaunias P. Cerebrofacial vascular disease. Orbit 2003; 22:89–102.CrossRefPubMedGoogle Scholar
  61. 61.
    Goh WHS, Lo R. Cerebellar hypoplasia, cavernous haemangioma and coarctation of the aorta. Dev Med Child Neurol 1993; 35:637–641.PubMedCrossRefGoogle Scholar
  62. 62.
    Etchevers HC, Couly G, Vincent C, Le Douarin NM. Anterior cephalic neural crest is required for forebrain viability. Development 1999; 126:3533–3543.PubMedGoogle Scholar
  63. 63.
    Etchevers HC, Vincent C, Le Douarin NM, Couly GF. The cephalic neural crest provides pericytes and smooth muscle cells to all blood vessels of the face and forebrain. Development 2001; 128:1059–1068.PubMedGoogle Scholar
  64. 64.
    Pascual-Castroviejo I. Vascular and nonvascular intracranial malformations associated with external capillary hemangiomas. Neuroradiology 1978; 16:82–84.CrossRefPubMedGoogle Scholar
  65. 65.
    Hirsch JF, Pierre-Kahn A, Renier D, Sainte-Rose C, Hoppe-Hirsch E. The Dandy-Walker malformation. A review of 40 cases. J Neurosurg 1984; 61:515–522.CrossRefPubMedGoogle Scholar
  66. 66.
    Wong IY, Batista LL, Alvarez H, Lasjaunias PL. Craniofacial arteriovenous metemeric syndrome (CAMS) 3 — a transitional pattern between CAMS 1 and 2 and spinal arteriovenous metameric syndromes. Neuroradiology 2003; 45:611–615.CrossRefPubMedGoogle Scholar
  67. 67.
    Pascual-Castroviejo I. The association of extracranial and intracranial vascular malformations in children. Can J Neurol Sci 1985; 12:139–148.PubMedGoogle Scholar
  68. 68.
    Mizuno Y, Korokawa T, Numaguchi Y, Goya M. Facial hemangioma with cerebrovascular anomalies and cerebellar hypoplasia. Brain Dev 1982; 4:375–378.PubMedGoogle Scholar
  69. 69.
    Murotani K, Hiramoto M. Agenesis of the internal carotid artery with a large hemangioma of the tongue. Neuroradiology 1985; 27:357–359.CrossRefPubMedGoogle Scholar
  70. 70.
    Schneeweiss A, Blieden LC, Shem-Tov A, Motro M, Feigel A, Neufeld HN. Coarctation of the aorta with congenital hemangioma of the face and neck and aneurysm or dilatation of subclavian or innominate artery. A new syndrome? Chest 1982; 82:186–187.CrossRefPubMedGoogle Scholar
  71. 71.
    Tortori-Donati P, Fondelli MP, Rossi A, Bava GL. Intracranial contrast-enhancing masses in infants with capillary haemangioma of the head and neck: intracranial capillary haemangioma? Neuroradiology 1999; 41:369–375.CrossRefPubMedGoogle Scholar
  72. 72.
    Burrows PE, Robertson RL, Mulliken JB, Beardsley DS, Chaloupka JC, Ezekowitz RA, Scott RM. Cerebral vasculopathy and neurologic sequelae in infants with cervicofacial hemangioma: report of eight patients. Radiology 1998; 207:601–607.PubMedGoogle Scholar
  73. 73.
    Bhattacharya JJ, Luo CB, Alvarez H, Rodesch G, Pongpech S, Lasjaunias PL. PHACES syndrome: a review of eight previously unreported cases with late arterial occlusions. Neuroradiology 2004; 46:227–233.CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2005

Authors and Affiliations

  • Jeyaledchumy Mahadevan
    • 1
  • Hortensia Alvarez
    • 1
  • Pierre Lasjaunias
    • 1
  1. 1.Diagnostic and Therapeutic Vascular Neuroradiology UnitBicêtre HospitalLe Kremlin-BicêtreFrance

Personalised recommendations